In parallel, programmed death-ligand 1 (PD-L1) is expressed in a variety of tumors, including melanoma, non-small cell lung cancer, Merkel cell carcinoma, breast cancer, and squamous cell carcinoma. Here, CD274 is linked to breast carcinoma.